EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology

William G. Dixon*, Loreto Carmona, Axel Finckh, Merete Lund Hetland, Tore K. Kvien, Robert Landewe, Joachim Listing, Paulo J. Nicola, Ulrik Tarp, Angela Zink, Johan Askling

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

66 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1596-1602
JournalAnnals of the Rheumatic Diseases
Volume69
Issue number9
DOIs
Publication statusPublished - Sep 2010

Cite this